Published in Kennedy Inst Ethics J on June 01, 2010
Enhancing Children against Unhealthy Behaviors-An Ethical and Policy Assessment of Using a Nicotine Vaccine. Public Health Ethics (2013) 0.94
The Affordable Care Act and the future of clinical medicine: the opportunities and challenges. Ann Intern Med (2010) 9.59
Changing the conversation about brain death. Am J Bioeth (2014) 8.71
Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med (2005) 8.25
Disclosing individual results of clinical research: implications of respect for participants. JAMA (2005) 8.15
A plea for pragmatism in clinical research ethics. Am J Bioeth (2008) 6.91
A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep (2003) 6.00
Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol (2006) 5.40
Bench to bedside: mapping the moral terrain of clinical research. Hastings Cent Rep (2008) 4.98
Money and distorted ethical judgments about research: ethical assessment of the TeGenero TGN1412 trial. Am J Bioeth (2007) 4.81
Principles for allocation of scarce medical interventions. Lancet (2009) 4.55
Ethical issues concerning research in complementary and alternative medicine. JAMA (2004) 4.48
The obligation to participate in biomedical research. JAMA (2009) 4.34
Clinical trials and medical care: defining the therapeutic misconception. PLoS Med (2007) 3.77
What makes killing wrong? J Med Ethics (2012) 3.74
Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med (2002) 3.62
Shared decision making to improve care and reduce costs. N Engl J Med (2013) 3.48
The cost of marginal medicine is too high. MedGenMed (2005) 3.33
Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. JAMA (2005) 3.14
The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06
Communicating the results of clinical research to participants: attitudes, practices, and future directions. PLoS Med (2008) 3.05
Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One (2010) 3.03
Informed consent for pragmatic trials--the integrated consent model. N Engl J Med (2014) 3.01
Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. BMJ (2008) 2.84
Rethinking risk-benefit assessment for phase I cancer trials. J Clin Oncol (2006) 2.73
Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol (2006) 2.72
Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol (2004) 2.52
Medicare's requirement for research participation as a condition of coverage: is it ethical? JAMA (2006) 2.43
Research with stored biological samples: what do research participants want? Arch Intern Med (2005) 2.43
The prognosis for changes in end-of-life care after the Schiavo case. Health Aff (Millwood) (2005) 2.40
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
Ethics of phase 1 oncology studies: reexamining the arguments and data. JAMA (2003) 2.28
Ethical guidance on the use of life-sustaining therapies for patients with Ebola in developed countries. Ann Intern Med (2014) 2.19
US health aid beyond PEPFAR: the Mother & Child Campaign. JAMA (2008) 2.17
The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. JAMA (2013) 2.16
Can research and care be ethically integrated? Hastings Cent Rep (2011) 2.15
Going off-label without venturing off-course: evidence and ethical off-label prescribing. Arch Intern Med (2009) 2.12
Community permission for medical research in developing countries. Clin Infect Dis (2005) 2.01
Deception in the pursuit of science. Arch Intern Med (2004) 1.99
Is placebo surgery unethical? N Engl J Med (2002) 1.94
Ethical issues in community-based participatory research: balancing rigorous research with community participation in community intervention studies. Prog Community Health Partnersh (2007) 1.90
The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs? Am J Public Health (2004) 1.88
The patents-based pharmaceutical development process: rationale, problems, and potential reforms. JAMA (2005) 1.83
The ethics of paying for children's participation in research. J Pediatr (2002) 1.80
What is a "minor" increase over minimal risk? J Pediatr (2005) 1.79
Viewpoint: what is the best and most ethical model for the relationship between mainstream and alternative medicine: opposition, integration, or pluralism? Acad Med (2005) 1.79
Clinical pragmatism: a method of moral problem solving. Kennedy Inst Ethics J (1997) 1.74
Participants in phase 1 oncology research trials: are they vulnerable? Arch Intern Med (2008) 1.74
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol (2008) 1.71
Will physicians lead on controlling health care costs? JAMA (2013) 1.71
Control group selection in critical care randomized controlled trials evaluating interventional strategies: An ethical assessment. Crit Care Med (2004) 1.71
The nocebo effect and its relevance for clinical practice. Psychosom Med (2011) 1.69
Health care reform and cost control. N Engl J Med (2010) 1.66
Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol (2007) 1.65
Ethics. The ethics of international research with abandoned children. Science (2007) 1.65
Is emergency research without initial consent justified?: the consent substitute model. Arch Intern Med (2010) 1.65
Why patients continue to participate in clinical research. Arch Intern Med (2008) 1.62
Ending concerns about undue inducement. J Law Med Ethics (2004) 1.55
Health care reform: why? What? When? Health Aff (Millwood) (2005) 1.50
Regional ethics organizations for protection of human research participants. Nat Med (2004) 1.48
Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med (2008) 1.47
A normative justification for distinguishing the ethics of clinical research from the ethics of medical care. J Law Med Ethics (2005) 1.47
Improving access to health care: a consensus ethical framework to guide proposals for reform. Hastings Cent Rep (2007) 1.47
Access and ability to pay: the ethics of a tiered health care system. Arch Intern Med (2007) 1.46
A historic moment for open science: the Yale University Open Data Access project and medtronic. Ann Intern Med (2013) 1.45
Can the United States buy better advance care planning? Ann Intern Med (2014) 1.41
Misunderstanding, period. IRB (2011) 1.40
ASCO core values. J Clin Oncol (2006) 1.40
Quality-improvement research and informed consent. N Engl J Med (2008) 1.40
Does random treatment assignment cause harm to research participants? PLoS Med (2006) 1.39
Clinical research and the physician-patient relationship. Ann Intern Med (2003) 1.39
The transparency imperative. Ann Intern Med (2013) 1.39
The moral duty to buy health insurance. JAMA (2012) 1.38
Defining death: the importance of scientific candor and transparency. Intensive Care Med (2014) 1.38
Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol (2002) 1.37
Enrolling the uninsured in clinical trials: an ethical perspective. Crit Care Med (2003) 1.37
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry (2002) 1.29
Money, coercion, and undue inducement: attitudes about payments to research participants. IRB (2012) 1.29
Placebo Effects in Medicine. N Engl J Med (2015) 1.29
The clinician-investigator: unavoidable but manageable tension. Kennedy Inst Ethics J (2003) 1.28
The dead donor rule and organ transplantation. N Engl J Med (2008) 1.28
Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey. Ann Intern Med (2015) 1.20
Tier 4 drugs and the fraying of the social compact. N Engl J Med (2008) 1.16
The randomized controlled trial as a demonstration project: an ethical perspective. Am J Psychiatry (2009) 1.15
How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond B Biol Sci (2011) 1.15
The quality of informed consent in a clinical research study in Thailand. IRB (2005) 1.13
Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol (2011) 1.13
PEPFAR and maximizing the effects of global health assistance. JAMA (2012) 1.12
Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations. J Clin Oncol (2008) 1.12
Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer. JAMA (2013) 1.11
Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond B Biol Sci (2011) 1.11
Patients' attitudes about the use of placebo treatments: telephone survey. BMJ (2013) 1.10
Evaluating the risks of clinical research. JAMA (2010) 1.09
Ethical framework for the use of sham procedures in clinical trials. Crit Care Med (2003) 1.08
Role of expectations in health. Curr Opin Psychiatry (2011) 1.08
Alternative medicine research in clinical practice: a US national survey. Arch Intern Med (2009) 1.07
Risks and benefits associated with novel phase 1 oncology trial designs. Cancer (2007) 1.07